MedPath

Smart Heart Trial: Structured Lifestyle Intervention for Overweight and Obese Youth With Operated Heart Defects

Not Applicable
Completed
Conditions
Congenital Heart Disease
Pediatric Obesity
Interventions
Behavioral: Lifestyle intervention
Registration Number
NCT02980393
Lead Sponsor
Kambiz Norozi
Brief Summary

This study is to assess whether a lifestyle intervention with diet, exercise and counselling in young patients will have a positive influence on their weight and overall well-being. This study will enrol patients between the ages of 7 to 17 years of age, who have congenital heart disease, and have been identified being overweight or obese. A total of 40 individuals will participate in this study. The study duration will last for 1 year.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • overweight or obese (BMI> 85%) patients
  • between 7-17 years of age
  • operated or non-operated congenital heart disease
  • reside in Southwestern Ontario
Exclusion Criteria
  • inability to comply with research testing or intervention components due to mental and/or physical disabilities, medications or comorbidities affecting weight or metabolic condition
  • involvement in any concurrent lifestyle intervention program

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Lifestyle interventionLifestyle interventionParticipants are guided by a fitness specialist who will help the participants to incorporate physical activity into their daily life. Based on the cardiologist assessment, an individual home-based exercise program will be developed. Participants are also guided and advised on nutrition with emphasis on low fat content and increased fiber. The nutrition counseling will focus on sustainable changes and will help participants to make healthy food choices.
Primary Outcome Measures
NameTimeMethod
Change in Baseline Fat Mass at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Dual energy x-ray absorptiometry (DEXA) will measure fat mass.

Change in Baseline Visceral Adipose Tissue at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Dual energy x-ray absorptiometry (DEXA) will measure visceral adipose tissue.

Change in Baseline Lean Mass at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Dual energy x-ray absorptiometry (DEXA) will measure lean mass.

Change in Baseline Bone Mineral Content at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Dual energy x-ray absorptiometry (DEXA) will measure bone mineral content.

Change in Baseline Percent Fat at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Dual energy x-ray absorptiometry (DEXA) will measure percent fat.

Change in Baseline Body Mass Index (BMI) at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

BMI is derived from body mass divided by the square of the body height

Change in Baseline Percent Android Fat at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Dual energy x-ray absorptiometry (DEXA) will measure percent android fat.

Change in Baseline Maximum Oxygen Consumption at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Maximal exercise graded treadmill test will determine maximal oxygen consumption.

Secondary Outcome Measures
NameTimeMethod
Change in Baseline Adiponectin at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Blood is drawn from patients who have been asked to fast for at least 10 hours.

Change in Baseline Physical Activity Levels at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Physical activity levels will be measured from accelerometers

Change in Baseline Self-Report Physical Activity Levels at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Physical activity levels will also be measured by the Physical Activity Questionnaire for Older Children

Change in Baseline Muscle function at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Leonardo Mechanograph® Ground Reaction Force Plate will assess jumping height.

Change in Baseline Transthoracic echocardiographic measurement at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Echo-cardiogram will be employed.

Change in Baseline Endothelial vasodilator function at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Peripheral arterial tonometry will assess endothelial vasodilator function.

Change in Baseline Creatinine at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Blood is drawn from patients who have been asked to fast for at least 10 hours.

Change in Baseline Electrocardiographic measurement at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Electrocardiogram

Change in Baseline Urea at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Blood is drawn from patients who have been asked to fast for at least 10 hours.

Change in Baseline Average Caloric Intake at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Average caloric intake is estimated from three-day food records.

Change in Baseline Electrolytes at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Blood is drawn from patients who have been asked to fast for at least 10 hours.

Change in Baseline Fasting Glucose at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Blood is drawn from patients who have been asked to fast for at least 10 hours.

Change in Baseline Serum Insulin at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Blood is drawn from patients who have been asked to fast for at least 10 hours.

Change in Baseline Quality of Life at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Pediatric Quality of Life Inventory Generic Core Scales

Change in Baseline Lipid Profile at 1 yearThis outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame

Blood is drawn from patients who have been asked to fast for at least 10 hours.

© Copyright 2025. All Rights Reserved by MedPath